These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8931770)

  • 1. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat.
    Grass S; Hoffmann O; Xu XJ; Wiesenfeld-Hallin Z
    Acta Physiol Scand; 1996 Nov; 158(3):269-73. PubMed ID: 8931770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
    Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
    Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
    Allen RM; Dykstra LA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
    Hao JX; Xu XJ
    Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and beta-endorphin administered intracerebroventricularly in the formalin pain model.
    Chung KM; Song DK; Huh SO; Kim YH; Choi MR; Suh HW
    Neuropeptides; 2000; 34(3-4):158-66. PubMed ID: 11021975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats.
    Haghparast A; Gheitasi IP; Lashgari R
    Eur J Pain; 2007 Nov; 11(8):855-62. PubMed ID: 17291798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effect in mice of intraperitoneal N-methyl-D-aspartate receptor antagonists in the formalin test.
    Berrino L; Oliva P; Massimo F; Aurilio C; Maione S; Grella A; Rossi F
    Eur J Pain; 2003; 7(2):131-7. PubMed ID: 12600794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
    Craft RM; Lee DA
    Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats.
    Plesan A; Hedman U; Xu XJ; Wiesenfeld-Hallin Z
    Anesth Analg; 1998 Apr; 86(4):825-9. PubMed ID: 9539609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of morphine analgesia by site-specific N-methyl-D-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time.
    Nemmani KVS; Grisel JE; Stowe JR; Smith-Carliss R; Mogil JS
    Pain; 2004 Jun; 109(3):274-283. PubMed ID: 15157688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats.
    Hoffmann O; Wiesenfeld-Hallin Z
    Neuroreport; 1996 Feb; 7(3):838-40. PubMed ID: 8733757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan.
    Bulka A; Wiesenfeld-Hallin Z; Xu XJ
    Brain Res; 2002 Jun; 942(1-2):95-100. PubMed ID: 12031857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are glycineB sites involved in the development of morphine tolerance?
    Kotlińska J
    Pol J Pharmacol; 2004; 56(1):51-7. PubMed ID: 15047977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextromethorphan differentially affects opioid antinociception in rats.
    Chen SL; Huang EY; Chow LH; Tao PL
    Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
    Fischer BD; Carrigan KA; Dykstra LA
    J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MK-801 prevents the development of behavioral sensitization during repeated morphine administration.
    Jeziorski M; White FJ; Wolf ME
    Synapse; 1994 Feb; 16(2):137-47. PubMed ID: 8197575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats.
    Kozela E; Danysz W; Popik P
    Eur J Pharmacol; 2001 Jun; 423(1):17-26. PubMed ID: 11438302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic differences in the antinociceptive effect of morphine and its potentiation by dextromethorphan in rats.
    Plesan A; Hoffmann O; Xu XJ; Wiesenfeld-Hallin Z
    Neurosci Lett; 1999 Mar; 263(1):53-6. PubMed ID: 10218909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.
    Tiseo PJ; Inturrisi CE
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1090-6. PubMed ID: 8450453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.